AzTrials
AzTrials

Chronic Kidney Disease, Population, Community, Multidisciplinary, EducationNCT03004898

Population-based Chronic Kidney Disease Cohort at Northern Taiwan

A study testing multidisciplinary renal education in people with Chronic Kidney Disease, Population, Community, Multidisciplinary, Education, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

CKD is a global endemic disease with increased comorbidities and mortality. The prevalence and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. The prevalence of CKD remains high; however, the awareness remains low. Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
What is being tested?
multidisciplinary renal education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10,000 participants
Where
1 siteTaiwan
Study dates
Feb 2013to May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • residents of Northern Taiwan

Who cannot join

  • pregnancy women, unwilling to participate

Trial locations and contacts

1 site in 1 country.

Taiwan1 site, 1 recruiting
  • Department of Nephrology, Chang Gung Memorial Hospital

    Keelung, 204

    I-Wen Wu, MD, +886-2-24313131 ext. 3170, fliawu@yahoo.com

    I-Wen Wu, MD

    Recruiting

Other trials in Taiwan

About this study

Official title: Preventing Progression of Renal Disease by Multidisciplinary Education - A Cohort Study at Northern Taiwan.

CKD is a global endemic disease with increased comorbidities and mortality. The prevalence and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. The prevalence of CKD remains high; however, the awareness remains low. Screening of unique risk factor and early diagnosis of CKD can improve outcome. Furthermore, data of renal education deep into the community remains limited. The aims of this study are:

  1. Explore risk factors associated with CKD in the community
  2. Establish multidisciplinary care model in the community
  3. Investigate mechanistic mediators for CKD and multidisciplinary education approached in behavioral , physiological, immune and metabolomics aspects
  4. Provide bio-specimen repository for future study
Being tested
multidisciplinary renal education
Medical subject headings
Renal Insufficiency, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • multidisciplinary renal educationBehavioural

    multidisciplinary CKD care involving case management nurse, dietitian, social worker, pharmacists.

Study groups in NCT03004898
Study groupRoleWhat they receive
education armExperimentalmultidisciplinary education: multidisciplinary CKD education involving case management nurse, dietitian, social worker, pharmacists.
Receives: Behavioral: multidisciplinary renal education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. eGFR < 60 mL/min

    change of renal function between groups

    Measured: through study completion, every 1 year

  2. albuminuria/creatinine ratio >=30

    change of proteinuria between groups

    Measured: through study completion, every 1 year

  3. proteinuria/creatine ratio >=150

    change of proteinuria between groups

    Measured: through study completion, every 1 year

Secondary outcomes (1)
  1. SF-36

    change of score between groups

    Measured: through study completion, every 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2016 (estimated)
  2. Study startFeb 2013
  3. Primary completionMay 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03004898
Sponsor's protocol ID
IWW-0006
Status last verified
Mar 2020
First submitted
14 Oct 2016
Last updated
10 Mar 2020
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Wu IW, Wang SY, Hsu KH, Lee CC, Sun CY, Tsai CJ, Wu MS. Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality--a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant. 2009 Nov;24(11):3426-33. doi: 10.1093/ndt/gfp259. Epub 2009 Jun 2.

    PubMed 19491379
  • Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS. The impact of self-management support on the progression of chronic kidney disease--a prospective randomized controlled trial. Nephrol Dial Transplant. 2011 Nov;26(11):3560-6. doi: 10.1093/ndt/gfr047. Epub 2011 Mar 17.

    PubMed 21414969

Questions about this trial

What is this clinical trial studying?

A study testing multidisciplinary renal education in people with Chronic Kidney Disease, Population, Community, Multidisciplinary, Education, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tsang-Tang Hsieh, MD (+886-2-27135211 ext. 3576, tth3388@adm.cgmh.org.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

eGFR < 60 mL/min (time frame: through study completion, every 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03004898, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in